Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1

by Jui-Cheng Tseng, James Cheng-Chung Wei, James Cheng-Chung Wei, James Cheng-Chung Wei, Atul Deodhar, Ruvie Martin, Brian Porter, Suzanne McCreddin, Zsolt Talloczy
Published 2020-11-01

Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

by Atul A. Deodhar, Corine Miceli‐Richard, Xenofon Baraliakos, Helena Marzo‐Ortega, Dafna D. Gladman, Ricardo Blanco, Ayan Das Gupta, Ruvie Martin, Jorge Safi Jr, Brian Porter, Abhijit Shete, James T. Rosenbaum
Published 2020-05-01